OWC PHARMACEUTICAL COM USD0.001 (OWCP)

0.65308+0.00308 ( +0.47385% ) Jun25

Instant Analysis On Any Stock…

Your Marijuana Trend Report Is Ready!

 

Instant Analysis On Any Stock…

Your Marijuana Trend Report Is Ready!

 

OWCP Detailed Quote

Last Trade: 0.65308
Trade Time: 3:59pm
Change: +0.00308
Perc Change: +0.47385%
Prev Close: 0.65000
Open: 0.64700
Day's Range: 0.61100 - 0.65400
Bid: N/A
EPS -0.03000
52wk Range: 0.00300 - 3.23000
Volume: 357556
Avg Vol: 24536
Market Cap: 94.58M
P/E (ttm): N/A
PES (ttm): -0.03000
Ask: N/A

OWCP Recent Headlines

  • OWC Pharmaceuticals Engages CFN Media to Cultivate New Investor Audience & Communicate with Existing Shareholders 06/19/2017 11:00 AMCFN Media Group , the leading agency and digital media network dedicated to the North American cannabis industry, today announced that OWC Pharmaceutical Research Corp. has engaged CFN Media to conduct ...
  • OWC Pharmaceutical Research Corp. Enters Into a Strategic Relationship With Germany-Based mediq Innovation Experts 05/31/2017 11:00 AMOWC Pharmaceutical Research Corp. (OWCP) and mediq Innovation Partners (mediq) are pleased to announce an agreement for the introduction of OWCP's active cannabinoid-based topical psoriasis cream to the German market. Frankfurt, Germany-based mediq has extensive experience, knowledge and a successful track record in enabling Israel-based companies to penetrate the European markets.
  • OWC Pharmaceutical Research Announces Update on Multiple Myeloma Study 05/03/2017 11:00 AMOWC Pharmaceutical Research Corp. (OWCP), ("OWC" or the "Company"), an Israeli-based research company engaged in the development of cannabinoid-based therapies targeting a variety of different medical conditions and disorders, today announced that the Scientific Advisory Team of its wholly owned Israeli subsidiary, One World Cannabis Ltd. ("OWC") has determined the road map for continuing the Multiple Myeloma study.
  • OWC Pharmaceutical Research Corp. to Present at Monaco Growth Forums in Monaco 04/17/2017 11:00 AMPETACH TIKVA, Israel, April 17, 2017 /PRNewswire/ -- The Monaco Growth Forums by Andreea Porcelli and OWC Pharmaceutical Research Corp. (OTC: OWCP), are pleased to announce that OWCP  has been invited ...
  • OWC Pharmaceutical Research Corp. Announces World-Wide Expression of Interest in its Cannabis-based Topical Cream for Treatment of Psoriasis and other Skin Disorders 04/05/2017 01:57 PMOWC Pharmaceutical Research Corp. (OWCP), ("OWC" or the "Company"), an Israeli-based research company engaged in the development of cannabinoid-based therapies targeting a variety of different medical conditions and disorders, today announced it has received expressions of interest from the scientific and medical communities world-wide as a result of its recently announce positive preliminary clinical efficacy tests results of its topical cream to treat Psoriasis. OWCP's scientific team, led by the renowned Dr. Yehuda Baruch, the Company's Chief Science Officer and OWC's Director of Research and Regulatory Affairs, and former Director of Israel's Ministry of Health Medical Management Division, previously reported trial results and concluded that post-application of OWC's unique, active cannabinoid-based topical cream formulation, there was up to 70% improvement in a variety of inflammation markers directly associated with Psoriasis.

FIND OUT HOW MUCH MOMENTUM IS DRIVING YOUR MARIJUANA STOCK!

AS SEEN ON
>>